Nanobiotechnologies in medicine: Nanodiagnostics and nanodrugs

被引：10

作者：

Archakov A.I. ^{[1
,2
]}

机构：

[1] Institute of Biomedical Chemistry, Russian Academy of Medical Sciences, Moscow 119121

[2] Russian State Medical University, Moscow

来源：

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry | 2010年 / 4卷 / 1期

关键词：

Fullerene; Supplement Series; Molecular Detector; Biomedical Chemistry; Optical Biosensor;

D O I：

10.1134/S1990750810010026

中图分类号：

学科分类号：

摘要：

[No abstract available]

引用

页码：2 / 14

页数：12

共 11 条

[1]

Freitas Jr. R., Nanomedicine, 1, pp. 2-9, (2005)

[2]

Anderson N.L., Anderson N.G., Mol. Cell. Proteomics, 1, pp. 845-867, (2002)

[3]

Archakov A.I., Ivanov Y.D., Lisitsa A.V., Zgoda V.G., Proteomics, 9, pp. 1326-1343, (2009)

[4]

Ivanov Y.D., Lisitsa A.V., Zgoda V.G., Proteomics, 7, pp. 4-9, (2007)

[5]

Archakov A.I., Ivanov Yu. D., Analytical nanobiotechnology for medicine diagnostics, Molecular BioSystems, 3, 5, pp. 336-342, (2007)

[6]

Patolsky F., Zheng G., Leiber C.M., Nanomedicine, 1, pp. 51-65, (2006)

[7]

Sigmundsson K., Masson G., Rice R., Beauchemin N., Obrink B., Determination of active concentrations and association and dissociation rate constants of interacting biomolecules: An analytical solution to the theory for kinetic and mass transport limitations in biosensor technology and its experimental verification, Biochemistry, 41, 26, pp. 8263-8276, (2002)

[8]

Ivanov Y.D., Govorun V.M., Bykov V.A., Archakov A.I., Proteomics, 6, (2006)

[9]

Ipatova O.M., Phosphogliv: Mechanism Deistviya i Primeneniie v Klinike, (2005)

[10]

Lindquist S., Engeenering and Medicine, pp. 1-5, (2003)

← 1 2 →